DEFROSIA 500

DEFROSIA 500 is a high-quality iron chelation therapy formulated with Deferasirox Dispersible Tablets 500 mg, designed to effectively manage chronic iron overload in patients undergoing repeated blood transfusions. Manufactured by Steris Healthcare Pvt. Ltd., DEFROSIA 500 offers a reliable, patient-friendly solution that helps reduce excess iron levels and protect vital organs from long-term damage.

What is DEFROSIA 500?

DEFROSIA 500 contains Deferasirox Dispersible Tablets 500 mg, a well-established oral iron chelator used in the treatment of conditions associated with iron overload such as thalassemia major, sickle cell disease, and other chronic anemias requiring frequent transfusions. Excess iron accumulation in the body can damage organs like the liver, heart, and endocrine glands, making iron chelation therapy essential for long-term patient care.

How DEFROSIA 500 Works

The active ingredient in DEFROSIA 500, deferasirox, works by binding to excess iron in the bloodstream. Once bound, the iron-deferasirox complex is excreted from the body primarily through feces. This process helps maintain safe iron levels and prevents complications caused by iron toxicity.

Its dispersible tablet form allows easy administration by dissolving the tablet in water or juice, ensuring better compliance, especially among pediatric and elderly patients.

Key Benefits of DEFROSIA 500

• Effective Iron Chelation: Helps remove excess iron from the body
• Prevents Organ Damage: Protects heart, liver, and endocrine organs
• Convenient Dosage Form: Dispersible tablets for easy intake
• Improves Patient Compliance: Suitable for long-term therapy
• Supports Chronic Conditions: Ideal for thalassemia and transfusion-dependent patients
• Once-Daily Dosing: Simplifies treatment regimen

Uses of Deferasirox Dispersible Tablets 500 mg

DEFROSIA 500 is primarily indicated for:

• Treatment of chronic iron overload due to repeated blood transfusions
• Management of iron overload in patients with thalassemia syndromes
• Iron chelation in patients with non-transfusion-dependent thalassemia (NTDT)
• Supporting long-term management of iron accumulation disorders

Dosage and Administration

DEFROSIA 500 should be taken exactly as prescribed by a qualified healthcare professional. The dosage is usually based on body weight, iron levels, and clinical condition.

How to take:

• Disperse the tablet in a glass of water or juice
• Stir well until completely dissolved
• Consume immediately on an empty stomach or as advised

Do not chew or swallow the tablet whole unless directed by a doctor.

Precautions and Safety Information

Before starting DEFROSIA 500, patients should inform their healthcare provider about any existing medical conditions, especially:

• Liver or kidney disorders
• Blood-related disorders
• History of gastrointestinal ulcers
• Ongoing medications or supplements

Important precautions:

• Regular monitoring of serum ferritin levels is required
• Kidney and liver function tests should be conducted periodically
• Avoid use during pregnancy and lactation unless prescribed
• Not recommended for patients with severe renal impairment

Possible Side Effects

Like all medications, DEFROSIA 500 may cause some side effects, although not everyone experiences them. Common side effects include:

• Nausea and vomiting
• Abdominal pain
• Diarrhea
• Skin rash
• Increased liver enzymes

In rare cases, serious side effects such as kidney dysfunction or gastrointestinal bleeding may occur. Immediate medical attention is advised if severe symptoms appear.

Storage Instructions

• Store in a cool and dry place below 25°C
• Protect from moisture and direct sunlight
• Keep out of reach of children

Why Choose DEFROSIA 500?

DEFROSIA 500 by Steris Healthcare Pvt. Ltd. is manufactured following stringent quality standards to ensure safety, efficacy, and reliability. Its dispersible formulation enhances ease of use, making it a preferred choice among healthcare professionals for managing iron overload conditions.

With a focus on patient-centric care, DEFROSIA 500 provides an effective solution for long-term iron chelation therapy, helping improve quality of life and reduce complications associated with excess iron accumulation.

Conclusion

If you or your patients are dealing with chronic iron overload, DEFROSIA 500 (Deferasirox Dispersible Tablets 500 mg) offers a trusted and clinically proven solution. With its powerful chelation action, convenient dispersible form, and strong safety profile under medical supervision, DEFROSIA 500 stands out as an essential therapy in modern hematology care.

For best results, always use DEFROSIA 500 under the guidance of a healthcare professional and follow regular monitoring protocols to ensure optimal treatment outcomes.